CENTROMERES, the segregation elements of eukaryotic chromosomes, are the platform for kinetochore assembly and subsequent microtubule attachment, and hence are absolutely essential for the stability of eukaryotic chromosomes. Centromeres also support sister chromatid cohesion at pericentric DNA, which keeps sisters together until anaphase ([@bib36]).

Most eukaryotes have so-called regional centromeres, which range in size from 35 to 100 kb in *Schizosaccharomyces pombe* to 0.1--5 Mb in humans and contain repeated sequences, that are usually assembled into heterochromatin \[reviewed in [@bib29]\]. In contrast, the *Saccharomyces cerevisiae* (hereafter, yeast) centromere, often called a point centromere, is only ∼125-bp long, and is nonrepetitive and nonheterochromatic \[see [@bib1] for a review of yeast centromeres and their associated proteins\].

Yeast centromeres contain three conserved elements (CDEs): CDEI (8 bp), CDEII (78--86 bp), and CDEIII (25 bp) ([Figure 1A](#fig1){ref-type="fig"}). CDEI is bound by [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528), which---depending on context---activates or represses RNA polymerase II transcription ([@bib6]; [@bib30]). Neither CDEI nor [*CBF1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) is essential, but loss of either reduces chromosome stability. CDEII varies somewhat in length and sequence but is always AT-rich. Its size and AT-richness are both essential for centromere function, probably because it is the binding site for a nucleosome containing [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528), the essential yeast centromere-specific histone H3 variant (cenH3, called CENP-A in humans) ([@bib47]; [@bib24]). *In vivo*, centromeric chromatin is thought to wrap around the [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) nucleosome, which might be facilitated by [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528), whose binding promotes DNA bending ([@bib37]; [@bib22]; [@bib45]). The size and sequence of CDEIII is essential as it provides a binding site for a four-protein complex called Cbf3, which is required for association of kinetochore proteins ([@bib1]).

![Cen-RNA is cell cycle-regulated and inhibited by [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528). (A) Schematic of centromeric DNA and its binding proteins ([@bib1]). [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) binds CDEI; CDEII wraps around a nucleosome containing [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528), a centromere-dedicated histone H3; and CDEIII is bound by a four-protein complex called Cbf3 consisting of [Ctf13](https://www.yeastgenome.org/locus/S000004700), [Skp1p](https://identifiers.org/bioentitylink/SGD:S000002736?doi=10.1534/genetics.119.302528), [Cep3p](https://identifiers.org/bioentitylink/SGD:S000004778?doi=10.1534/genetics.119.302528), and [Cbf2p](https://identifiers.org/bioentitylink/SGD:S000003372?doi=10.1534/genetics.119.302528). Blue arrows indicate the position of primers used to amplify centromeric DNA by qPCR and red arrows indicate the position of primers used to amplify cen-RNA by RT-PCR. The primers are specific for each centromere. (B--D) The pattern of cen-RNA abundance at [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528) (B), [CEN9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528) (C), and [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) (D) in 24°-grown WT (blue squares) or [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ (red circles) cells as they move through a synchronous cell cycle. Samples were collected at the indicated times after release from α factor arrest, total RNA was purified, and cen-RNAs detected by RT-PCR. The approximate timings of cell cycle transitions for WT (blue rectangles) and [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells (red rectangles) are indicated beneath the graphs, as determined from FACS data (Figure S1A). Data are presented as (\[RNA\]~target\ gene~/\[[ACT1](https://identifiers.org/bioentitylink/SGD:S000001855?doi=10.1534/genetics.119.302528)\]~control~). Scales are not the same for the different centromeres. (B--D) The amounts of cen-RNA \[(E) [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528), (F) [CEN9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528), and (G) [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528)\] in 30°-grown asynchronous cells determined using RT-PCR. Cen-RNA levels were determined in WT (blue bars) and [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ (red bars) cells. The levels of cen-RNA at a given centromere in WT cells were defined as one; the fold increases in the levels in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells are shown above the red bars. Error bars in (E--G) indicate 1 SD from the average value of three independent experiments. *P*-values were obtained using unpaired two-tailed Student's *t*-tests. In all figures, \* *P* ≤ 0.05, *\*\** *P* ≤ 0.01, \*\*\* *P* ≤ 0.001, and \*\*\*\* *P* ≤ 0.0001. CDE, conserved elements; cen-RNA, centromeric RNA; ChIP, chromatin immunoprecipitation; qPCR, quantitative PCR; WT, wild-type.](465f1){#fig1}

Regional and point centromeres both require cenH3 nucleosomes to form functional kinetochores ([@bib51]). While the yeast centromere contains a single cenH3 nucleosome ([@bib11]; [@bib17]; [@bib24]), regional centromeres have multiple cenH3 nucleosomes ([@bib29]). Multiple kinetochore microtubules bind to each regional centromere, while there is a single kinetochore microtubule bound to each yeast centromere ([@bib1]). Thus, the budding yeast centromere and its kinetochore are scaled-down versions of regional centromeres, yet they share many features with the more complex regional centromeres, including many conserved kinetochore proteins.

Although studied mainly in the context of regional centromeres, centromeric RNA (cen-RNA) transcripts have been described in diverse organisms \[reviewed in [@bib5] and [@bib48]\]. At many regional centromeres, cen-RNA acts in concert with RNA interference to form heterochromatin. In addition, there is considerable evidence linking cen-RNAs directly to the segregation function of centromeres. For example, increases and decreases in cen-RNA levels correlate with decreased chromosome stability ([@bib5]; [@bib48]). Although there are multiple models for how cen-RNAs affect centromere segregation, a unifying model for their function has not emerged in part because it can be difficult to distinguish the effects of cen-RNAs on heterochromatin formation *vs.* their effects on chromosome segregation. As *S. cerevisiae* centromeres are not heterochromatic, analysis of the functions of its cen-RNAs is theoretically less complicated.

Here, we investigate the occurrence and regulation of cen-RNA in budding yeast. The impetus for this work was the finding that the [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) DNA helicase binds robustly to all centromeres, and this binding is cell cycle-regulated, occurring in late S/G2 phase, after centromere replication ([@bib9]). Because [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) efficiently displaces RNA from RNA--DNA hybrids ([@bib2]; [@bib55]), we considered the possibility that it might remove cen-RNA from centromeres. Here, we report that the appearance of yeast cen-RNA was cell cycle-regulated, occurring in mid--late S phase, about the same time that [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) binds centromeres. Cen-RNAs were present in very low amounts in wild-type (WT) cells owing in part to [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) inhibition of cen-RNA production. As [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) binding was transiently lost in late S phase when cen-RNAs were detected, [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) likely acts directly to inhibit cen-RNA synthesis. [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) binding increased in Pif1-depleted cells, which could reflect a role for [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) in [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) removal. Cen-RNA levels were higher in the absence of RNaseH1, which removes and degrades RNA in RNA--DNA hybrids, an increase that was limited to mid--late S phase. Likewise, cen-RNAs were more abundant in mid--late S phase in cells deficient for [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) and [Rrm3](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528), a homolog of [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528). Together, these data suggest that RNaseH1, [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528), and [Rrm3](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528) contribute to cen-RNA release from centromeres late in the cell cycle. When cen-RNA was made at high levels throughout the cell cycle, [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding was deregulated.

Materials and Methods {#s1}
=====================

Yeast strains {#s2}
-------------

Yeast strains, plasmids, and primers used in this study are listed in Supplemental Material, Table S1 and S2. All strains were derivatives of YPH499 ([@bib44]). Deletions of genes eliminated the entire ORF. As expected, the [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ strain constructed for these experiments was slow growing and benomyl-sensitive, and both phenotypes were suppressed by a centromere plasmid containing [*CBF1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) ([@bib6]) (Figure S1, C and E). Additionally, [*MET17*](https://identifiers.org/bioentitylink/SGD:S000004294?doi=10.1534/genetics.119.302528) mRNA levels in the same RNA samples used to monitor cen-RNA were ∼50% lower in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ *vs.* WT cells ([@bib49]; [@bib25]; [@bib38]) (Figure S1D). Deletions and tagged genes were confirmed by both Southern and PCR analyses. Because terminally tagged alleles of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) and [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) are not functional ([@bib47]; [@bib54]), both proteins were internally tagged with nine MYC epitopes as described ([@bib12]). For [CBF1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528), the epitopes were after codon 9 ([@bib31]) and for [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528), after codon 81 ([@bib32]). The structures of the tagged [CBF1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) genes were confirmed by PCR, Southern analysis (Figure S4A), sequencing, and phenotypic analyses. Cbf1-MYC cells had WT benomyl sensitivity (Figure S4C) and grew about as well as WT cells (Figure S4D). In asynchronous chromatin immunoprecipitations (ChIPs), [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)-MYC bound specifically to six centromeres but not to control sites ([Figure 2, E--H](#fig2){ref-type="fig"} and Figure S3, C--E). These analyses were important because the size of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)-Myc on a western was 100 kDa rather than the predicted size of 50 kDa (Figure S4B). The difference from the expected size was probably due to the internal tag. Asynchronous cultures were grown at 30°; synchronies were done at 24°.

![[Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) binding to centromeres is cell cycle-regulated. (A--D) WT cells expressing [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)-MYC and growing at 24° were synchronized as described in [Figure 1](#fig1){ref-type="fig"}. Samples were removed at the indicated times for ChIP-qPCR analysis of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)-MYC binding (red circles) to (A) [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528), (B) [CEN9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528), (C) [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528), and (D) [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528). Scales are not the same on all panels. ChIP-qPCR was carried out in parallel on a no-tag strain (blue squares). (E--H) show levels of Cbf1-MYC binding in 30°-grown asynchronous cells (red bars) and in a no-tag strain (blue bars). [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)-Myc binding was determined at (E) [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528), (F) [CEN9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528), (G) [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528), and (H) [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528). Values are the average of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)-MYC binding in three independent colonies. The fold changes in the levels of binding on a given CEN of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)-MYC relative to WT are shown above the red bars. Error bars and statistical analyses are as in [Figure 1](#fig1){ref-type="fig"}. ChIP, chromatin immunoprecipitation; qPCR, quantitative PCR; WT, wild-type.](465f2){#fig2}

Cell synchrony {#s3}
--------------

Cells were synchronized and analyzed at 24° as described ([@bib9]). Cells were arrested in α factor (0.015 ng/ml; Princeton University) and collected at 15-min intervals after α factor removal. The quality of each synchrony was monitored by flow cytometry ([@bib9]). For each strain, synchronies were done at least three times on progeny of independent colonies. Samples were analyzed for DNA by ChIP-quantitative PCR (qPCR) and for RNA by reverse transcription polymerase chain reaction (RT-PCR).

RNA purification and RT-PCR {#s4}
---------------------------

Total RNAs were purified from synchronized and asynchronized cells using a RNeasy Mini Kit (\#74106; QIAGEN, Valencia, CA). DNA was eliminated by digestion with a TURBO DNA-free Kit (\#AM1907; Invitrogen, Carlsbad, CA). Then, 500 ng of total RNA was analyzed by RT-PCR (SYBR Green One-Step Kit, \#172--5151; Bio-Rad, Hercules, CA) as indicated by the manufacturer. The primer sets for RT-PCR are described in Table S2. The process ran for 45 cycles for cen-RNA and for the [ACT1](https://identifiers.org/bioentitylink/SGD:S000001855?doi=10.1534/genetics.119.302528) control.

ChIP and qPCR {#s5}
-------------

Asynchronous cells were grown in 50 ml of YPD at 30° and harvested at an OD~660~ of 0.5. Cells were cross-linked in 1% formaldehyde for 5 min, then quenched with 2.5 ml (2.5 M) glycine for 5 min. Chromatin purification was carried out as described ([@bib9]). Cells were incubated overnight at 4° in 0.02 µg/µl of anti-MYC monoclonal antibody (\#631206; Takara) and then coupled to 80 µl of Dynabeads protein G (\#10004D; Thermo Fisher Scientific; 4 hr at 4°). Reverse cross-linking of DNA was performed and DNA was purified by QIAquick PCR Purification kit (\#28106; QIAGEN). Chromatin immunoprecipitate and input DNA were analyzed by qPCR using iQ SYBR Green Supermix (\#170-8882; Bio-Rad) and the CFX96 real-time system (Bio-Rad). Primers are listed in Table S2. At least three biological replicates were conducted for each ChIP. WT cells without a Myc-tagged protein were used as a negative control. ChIP-qPCRs were quantified by (\[ChIP/Input\] Target site/\[ChIP/Input\] [ARO1](https://identifiers.org/bioentitylink/SGD:S000002534?doi=10.1534/genetics.119.302528)). Binding to the telomere of chromosome VI-R was used as a negative control.

Western blotting {#s6}
----------------

Western blotting was carried out as in [@bib50]. Briefly, cell extract was mixed with 1 × SDS-PAGE sample buffer, boiled for 10 min, and pelleted. Samples were analyzed on 15% (37.5:1 polyacrylamide:bis-acrylamide) SDS-PAGE gels and run at 20 V/cm at room temperature. The proteins were transferred to a nitrocellulose membrane at 4° and blocked with 5% nonfat milk in TBST at room temperature using standard protocols. The blot was probed with an anti-MYC monoclonal antibody (\#631206; Takara), which was diluted 1:500, and visualized with an HRP-conjugated secondary antibody and ECL detection reagents (GE Healthcare).

Loss rate assay for centromere plasmid {#s7}
--------------------------------------

Plasmid loss assays were carried out as described ([@bib9]). The plasmid loss rates are based on three independent experiments for each strain. The plasmid used for loss rates was the [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528) plasmid pRS316 ([@bib44]).

Benomyl sensitivity {#s8}
-------------------

Cells were grown overnight in YPD at 30°. Indicated strains were spotted in five times serial dilutions from 3 × 10^7^ cells per spot on YPD plates with and without benomyl (10 μg/ml), and grown at 30° for 3 days.

Two-dimensional agarose gel electrophoresis {#s9}
-------------------------------------------

Replication intermediates were analyzed by standard two-dimensional (2D) agarose gel electrophoresis techniques performed on total genomic DNA isolated from asynchronous cells ([@bib3], [@bib4]; [@bib19]). Cells were collected in log phase at an optical density of OD~660~ of ∼0.6. Collected DNA was digested with *Mfe*I. In the first dimension, DNA was separated in 0.4% agarose at room temperature for 20 hr at 2.0 V/cm. The second dimension was run for 15 hr in 1.1% agarose containing ethidium bromide (0.3 µg/ml) at 4.4 V/cm at 4°. Southern blots were probed using a ^32^P-labeled probe, whose position is indicated in [Figure 5](#fig5){ref-type="fig"}. The extent of pausing was obtained as described ([@bib9]). Quantification of pausing was done in two or more different biological replicates, and was normalized to the WT pause signal to obtain fold increase in the pause in a mutant strain relative to pausing in the otherwise isogenic WT strain.

Data availability {#s10}
-----------------

Strains and plasmids are available upon request. The authors affirm that all data necessary for confirming the conclusions of the article are present within the article, figures, tables, and Supplemental Materials. Supplemental material available at Figshare: <https://doi.org/10.25386/genetics.8939873>.

Results {#s11}
=======

Cen-RNA is cell cycle-regulated, with highest abundance in late S phase {#s12}
-----------------------------------------------------------------------

The [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) 5′--3′ DNA helicase binds centromeres in late S/G2 phase ([@bib9]). To determine if [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) has a role in cen-RNA regulation, we first determined the time of cen-RNA appearance. In this paper, we mostly examined three centromeres---[CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528), [9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528), and [13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528)---which were chosen because all three were studied in an earlier paper on cen-RNAs ([@bib39]). Because it was used for replication and mini-chromosome loss studies, in some experiments, [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528) was also examined. Each centromeric DNA and its RNA product was detected by a different set of primers that were unique to a given centromere ([Figure 1A](#fig1){ref-type="fig"}). We monitored cen-RNA abundance by RT-PCR as its low abundance and heterogenous size made it difficult to detect with northern analyses (data not shown). Controls indicate that RT-PCR detects cen-RNA; *e.g.*, samples were DNase treated prior to RT-PCR (TURBO DNA; Invitrogen), and no product was obtained when samples were treated with RNase A prior to amplification or if reverse transcriptase was omitted (Figure S1B).

To determine the time of cen-RNA production, a synchronized population of WT cells was obtained by arresting the culture in late G1 phase by incubation in α factor at 24°. Cells were then released from α factor and RT-PCR was used to monitor cen-RNA at three centromeres at 15 min intervals throughout the synchronous cell cycle ([Figure 1, B--D](#fig1){ref-type="fig"}, blue squares; primers used to amplify cen-RNA were specific for each centromere). Synchronies were done at 24° because it is easier to detect cell cycle transitions in cells growing more slowly than at the optimal growth temperature of 30°. Progression through the cell cycle was monitored by FACS (see Figure S1 and Figure S2 for FACS of synchronized cells for the WT and mutant strains studied herein). Synchronies were done in triplicate on cultures generated from three independent colonies of a given strain.

At [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528), cen-RNA was detectable at 15 min after release from α factor (early S phase), peaked in abundance at 45--60 min (late S phase), and decreased to almost background levels by 90 min (post S phase) ([Figure 1B](#fig1){ref-type="fig"}). Appearance of cen-RNA was somewhat later for [CEN9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528), first evident at 30 min, peaking at 45--60 min, and no longer detectable by 75 min ([Figure 1C](#fig1){ref-type="fig"}). Likewise, at [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528), cen-RNA was low until 45 min and was back to background levels by 90 min ([Figure 1D](#fig1){ref-type="fig"}). Thus, like the binding of [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) to centromeres ([@bib9]), the appearance of cen-RNA at all three centromeres was cell cycle-regulated and occurred mainly in mid--late S phase.

We also determined the levels of cen-RNA in asynchronous WT cultures grown at 30° ([Figure 1, E--G](#fig1){ref-type="fig"}; blue bars). RNA values for 30°-grown cells cannot be compared directly to values for 24°-grown cells because yeast grows faster at 30° than at 24°([@bib9]). Levels of cen-RNA varied from centromere to centromere: for example, there was 14 times more cen-RNA at [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528) ([Figure 1E](#fig1){ref-type="fig"}) than at [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) ([Figure 1G](#fig1){ref-type="fig"}). However, even at [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528), cen-RNAs levels were very low. In asynchronous cells, cen-RNA was detected only after ∼30 PCR cycles, compared to 16--17 cycles for the abundant [ACT1](https://identifiers.org/bioentitylink/SGD:S000001855?doi=10.1534/genetics.119.302528) RNA and ∼26 cycles for the low-abundance telomerase RNA, which is present at ∼20--30 molecules per cell ([@bib34]; P. D. Garcia *et al.*, unpublished results).

While this manuscript was in revision, another group published a paper on yeast cen-RNA whose results partially overlap those reported here ([@bib28]). This group also used RT-qPCR to detect cen-RNA. They focused their analysis on [CEN1](https://identifiers.org/bioentitylink/SGD:S000006463?doi=10.1534/genetics.119.302528), [3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528), and [8](https://identifiers.org/bioentitylink/SGD:S000006469?doi=10.1534/genetics.119.302528). In agreement with our data, they showed that cen-RNAs were present in very low amounts, estimated at considerably lower than one molecule per cell, and were similarly cell cycle-regulated (their cell cycle experiments were done at 28° so the timing of events is not directly comparable to our experiments). They also reported that cen-RNAs are poly-adenylated, and large and heterogenous in size (462--1754 nt). More recently, they reported that cen-RNA levels are elevated in two strains defective in exosome-mediated degradation of nuclear RNA ([@bib27]).

Cbf1 inhibits cen-RNA {#s13}
---------------------

[Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528), a helix-loop-helix sequence-specific DNA-binding protein, binds to the CDEI motif of yeast centromeres ([Figure 1A](#fig1){ref-type="fig"}), as well as to the promoters of multiple genes, whose transcription it regulates ([@bib6]; [@bib30]). Depending on the gene, [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) has positive or negative effects on transcription.

To determine the effects of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) on cen-RNA, we monitored the abundance of cen-RNAs at [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528), 9, and 13 at 30° in asynchronous [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells ([Figure 1, E--G](#fig1){ref-type="fig"}; red bars). Cen-RNA levels were ∼5--12× higher in asynchronous [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells than in WT cells (6.5× higher at [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528), 4.9× at [CEN9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528), and 11.9× at [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528)) ([Figure 1, E--G](#fig1){ref-type="fig"}). Of the three centromeres, the fold increase in cen-RNA in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells was greatest at [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528). However, because [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) cen-RNA was less abundant in WT cells than [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528) or [CEN9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528) RNA, levels of [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) RNA were still lower in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells than at the other two centromeres. High levels of cen-RNA were suppressed by introducing a centromere plasmid containing a WT copy of [*CBF1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) (Figure S1C). Although the inhibitory effects of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) on the production of cen-RNA are in agreement with [@bib28]), an earlier paper found that [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) activates cen-RNA transcription ([@bib39]). The reason for this discrepancy is not clear. In combination with other data ([@bib28]), [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) represses transcription at five of five centromeres. Cen-RNA levels are also higher (1.5--2 times higher than WT) at [CEN1](https://identifiers.org/bioentitylink/SGD:S000006463?doi=10.1534/genetics.119.302528), 3, and 8 in [*htz1*](https://identifiers.org/bioentitylink/SGD:S000005372?doi=10.1534/genetics.119.302528)Δ cells, where [Htz1](https://identifiers.org/bioentitylink/SGD:S000005372?doi=10.1534/genetics.119.302528) is a variant histone H2A that binds near centromeres as well as at many promoters ([@bib28]). Epistasis experiments indicate that [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) and [Htz1](https://identifiers.org/bioentitylink/SGD:S000005372?doi=10.1534/genetics.119.302528) affect CEN transcription by different mechanisms.

Cbf1 inhibits cen-RNA production throughout the cell cycle {#s14}
----------------------------------------------------------

To determine when [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) represses cen-RNA expression, we synchronized [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells using the α factor protocol described above and determined cen-RNA levels by RT-qPCR throughout the cell cycle at 24° ([Figure 1, B--D](#fig1){ref-type="fig"}, red circles). Although [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells grew significantly slower than WT cells at both 24 and 30° (Figure S1F), FACS analysis showed that they spent about the same fraction of the cell cycle in each cell cycle phase (Figure S2). For all three centromeres, there was significantly more cen-RNA at each time point in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ (red circles) compared to WT cells (blue squares) ([Figure 1, B--D](#fig1){ref-type="fig"}; *P* \< 0.01). Therefore, [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) represses the production of cen-RNA and is also largely responsible for its cell cycle-regulated expression.

Cbf1 centromere binding is cell cycle-regulated {#s15}
-----------------------------------------------

To gain insight into the mechanism by which [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) inhibits cen-RNA transcription, we determined if it was centromere-associated at the time when cen-RNA appears. [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)-MYC cells were synchronized, and [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)-MYC binding to [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528), 6, 9, and 13 was determined by ChIP-qPCR at 24° ([Figure 2, A--D](#fig2){ref-type="fig"} and Figure S3, A and B). The pattern of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)-MYC binding was very similar at the four centromeres (red circles). Binding was highest in late G1 phase (0 time point), decreased as cells moved through S phase, and was lowest at 45 min. The time of lowest [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)-MYC binding corresponded to the time of peak appearance of cen-RNAs in WT cells ([Figure 1, B--D](#fig1){ref-type="fig"}, blue squares). Levels of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) binding were also examined at six centromeres by ChIP-qPCR in asynchronous cells grown at 30° ([Figure 2, E--H](#fig2){ref-type="fig"} and Figure S3, C and D). Levels of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) binding varied somewhat from centromere to centromere with particularly high levels at [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) (31× the no-tag control; [Figure 2G](#fig2){ref-type="fig"}). Thus, [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) produced less cen-RNA and bound more [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) than the other centromeres examined. We conclude that the repressive effects of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) on centromere transcription are relieved by removal of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528).

Cen-RNA levels are suppressed in mid--late S phase by RNaseH1 {#s16}
-------------------------------------------------------------

[Rnh1](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528) removes and degrades RNA in RNA--DNA hybrids (R-loops) ([@bib8]; [@bib56]). Because the R-loop-specific S9.6 antibody stains human centromeres, and this staining is RNaseH1-sensitive, human cen-RNA is thought to be in R-loops ([@bib21]). To determine if *S. cerevisiae* cen-RNA was RNaseH1-sensitive, cen-RNA levels were determined in [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ cells. In 30°-grown asynchronous [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ cells, cen-RNA abundance was significantly higher than in WT cells at [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528), 9 and 13 ([Figure 3, A--C](#fig3){ref-type="fig"}; 1.7--2.4× higher; *P* \< 0.05). In contrast, levels of the [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) regulated [*MET17*](https://identifiers.org/bioentitylink/SGD:S000004294?doi=10.1534/genetics.119.302528) mRNA were not affected by deleting [*RNH1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528) (Figure S1D; *P* \> 0.05). Deletion of [*RNH201*](https://identifiers.org/bioentitylink/SGD:S000005016?doi=10.1534/genetics.119.302528), the catalytic subunit of RNaseH2, had little or no effect on cen-RNA levels ([Figure 3, A--C](#fig3){ref-type="fig"}).

![Cen-RNA abundance is increased in [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ cells in mid--late S phase. Cen-RNA levels were determined by RT-PCR in asynchronous cultures grown in YPD at 30° (A) [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528), (B) [CEN9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528), and (C) [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) in WT and mutant strains (names of strains are under bars). The numbers above the bars indicate the fold difference in cen-RNA in mutants compared to WT cells. Black asterisks indicate *P*-values relative to WT. Red asterisks indicate *P*-values relative to [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ. Green asterisks indicate *P*-values relative to [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ. (D--F) show cen-RNA levels in 24°-grown cells synchronized as described in the legend for [Figure 1](#fig1){ref-type="fig"} at (D) [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528), (E) [CEN9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528), and (F) [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528). RNA levels in WT cells (blue square) and [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ cells (purple square) are shown at each time point. The scale for (D) ([CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528)) is different from those of (E and F). The approximate timings of the cell cycle transitions for WT (blue rectangle) and [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ (purple rectangle) are indicated beneath the graphs, as determined by FACs analysis (Figure S1A and Figure S2F). cen-RNA, centromeric RNA; WT, wild-type.](465f3){#fig3}

We also examined the impact of RNaseH1 on cen-RNA throughout a synchronous cell cycle at 24° ([Figure 3, D--F](#fig3){ref-type="fig"}; purple squares). At all three centromeres, cen-RNA was significantly higher (*P* \< 0.001) in [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ *vs.* WT cells (blue squares). In contrast to the cell cycle-wide increase seen in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ, the increase in cen-RNA in [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ cells was limited to late S phase (45--75 min for [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528); [Figure 3D](#fig3){ref-type="fig"}; 60 and 75 min for [CEN9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528) and 13; [Figure 3, E and F](#fig3){ref-type="fig"}).

To determine if [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) and RNase H1 increased cen-RNA by the same mechanism, we determined cen-RNA levels in 30°-grown asynchronous [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells ([Figure 3, A--C](#fig3){ref-type="fig"}). At all three centromeres, levels of cen-RNA were significantly elevated in the double mutant compared to either single mutant (for direct comparison, the values for cen-RNA in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells from [Figure 1, E--G](#fig1){ref-type="fig"} are reshown in [Figure 3, A--C](#fig3){ref-type="fig"}). Thus, [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) and RNaseH1 affect cen-RNA levels by different mechanisms.

The increase in cen-RNA in [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ cells suggests a model where yeast cen-RNA is in R-loops. However, in WT yeast cells, cen-RNAs are not precipitated by the S9.6 antibody ([@bib14]; [@bib46]; [@bib52]) (our unpublished results). Thus, it is possible that the effects of RNaseH1 deletion on cen-RNA levels are indirect.

Cen-RNA levels are suppressed in mid--late S phase by Pif1 and Rrm3 {#s17}
-------------------------------------------------------------------

[Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) and [Rrm3](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528) are members of the [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) family of 5′--3′ DNA helicases that are present in almost all eukaryotes, and some bacteria \[reviewed in [@bib13] and [@bib41]\]. The multifunctional [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) has numerous functions, including maintenance of mitochondrial DNA, inhibition of telomerase, promoting replication past G-quadruplex motifs, and facilitating break-induced replication. [Rrm3](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528) is best known for promoting fork progression past nonnucleosomal proteins complexes, including those at centromeres and tRNA genes ([@bib20]; [@bib9]). [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) also promotes replication at centromeres ([@bib9]) and tRNA genes ([@bib40]; [@bib50]), but only in [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ cells. Because [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) binds robustly to all centromeres late in the cell cycle ([@bib9]) and actively unwinds RNA--DNA hybrids ([@bib2]; [@bib55]), we tested the effects of [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) (and [Rrm3](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)) on cen-RNA ([Figure 4](#fig4){ref-type="fig"}). Because [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)*-m2* cells grow much better than [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)Δ cells, which are respiratory-deficient, we used [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)*-m2* cells, which have reduced nuclear but normal mitochondrial [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) functions ([@bib43]; [@bib35]; [@bib42]; [@bib53]).

![Cen-RNA abundance is increased in late S phase in cells lacking [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) and [Rrm3](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528). Cen-RNA levels were determined by RT-PCR in asynchronous cultures grown in YPD at 30° at (A) [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528), (B) [CEN9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528), and (C) [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) in WT and mutant strains (names of strains are under bars). The numbers above the bars indicate the fold differences in cen-RNA in mutants compared to WT cells. Black asterisks indicate *P*-values relative to WT. Red asterisks indicate *P*-values relative to [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)*-m2* [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ. Green asterisks indicate *P*-values relative to [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ. (D--F) show cen-RNA levels in 24°-grown cells synchronized as described in [Figure 1](#fig1){ref-type="fig"} legend at (D) [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528), (E) [CEN9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528), and (F) [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528). The scales for the three panels are different. RNA levels in WT cells (blue square) and *pif1-m2* [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ cells (orange square) are shown. The approximate timings of the cell cycle transitions for WT (blue rectangle) and *pif1-m2* [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ (orange square) are indicated below the graphs as determined by FACs data (Figure S1A and Figure S2G). (G--I) show [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)-Myc binding in WT and mutant strains (names of strains are under bars). The numbers above the bars indicate the fold differences in [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)-Myc binding to mutant strains. cen-RNA, centromeric RNA; NS, not significant; WT, wild-type.](465f4){#fig4}

In asynchronous cells growing at 30°, the amount of cen-RNA at [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528), [9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528), and [13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) was not significantly different in [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)*-m2* or [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ compared to WT cells (*P* \> 0.05; [Figure 4, A--C](#fig4){ref-type="fig"}). However, the amount of cen-RNA was about two-to-three times higher in *pif1-m2* [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ *vs.* WT cells, and these differences were significant at all three centromeres ([Figure 4, A--C](#fig4){ref-type="fig"}; *P* \< 0.01 at [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528) and [9](https://www.yeastgenome.org/locus/S000006470), and *P* \< 0.05 at [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528)). The amount of cen-RNA was even higher in asynchronous [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)*-m2* [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ cells, and again this difference was significant compared to either [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)*-m2* [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ or [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ cells ([Figure 4, A--C](#fig4){ref-type="fig"}; *P* \< 0.05; the data for [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ cells are from [Figure 3, A--C](#fig3){ref-type="fig"}; *P* \< 0.05).

Similar results were seen for 24°-grown synchronized cells ([Figure 4, D--F](#fig4){ref-type="fig"}). There was no significant difference in cen-RNA levels in [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)*-m2* or [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ single mutants in late S/G2 phase (Figure S5). However, for [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528) and [9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528), cen-RNA was significantly higher at 45--70 min in doubly mutant [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)*-m2* [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ (orange squares) compared to WT cells (blue squares) (*P* \< 0.05). Effects on cen-RNA levels were not detected at [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) in synchronized doubly mutant cells ([Figure 4F](#fig4){ref-type="fig"}), perhaps because the lower temperature provides more time for RNaseH1 to act at this centromere. However, cen-RNA levels were almost three times higher at [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) in 30°-grown asynchronous [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)*-m2* [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ cells (*P* \< 0.05; [Figure 4C](#fig4){ref-type="fig"}).

These data suggest that [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) and [Rrm3](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528) have redundant functions in removal of cen-RNA. Given that R-loops are preferred substrates for both [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) ([@bib2]; [@bib55]) and Pfh1, the *S. pombe* Pif1 family helicase ([@bib33]), it is possible that [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)/[Rrm3](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528) act in parallel with RNaseH1 to displace cen-RNA from centromeric DNA. Unlike RNaseH1, DNA helicases cannot degrade the RNA they release. Thus, helicase-released cen-RNA is probably degraded by the exosome ([@bib27]).

Cbf1 binding to centromeres is reduced in Pif1-depleted cells {#s18}
-------------------------------------------------------------

[Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) centromere binding ([@bib9]) and [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) removal both occur in late S phase ([Figure 2, A--D](#fig2){ref-type="fig"}). Because [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) displaces [Rap1](https://identifiers.org/bioentitylink/SGD:S000005160?doi=10.1534/genetics.119.302528) from DNA *in vitro* ([@bib23]), and [Rrm3](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528) promotes replication fork progression past stable protein complexes ([@bib20]), we tested if one or both helicases affect [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) removal from centromeres. In asynchronous cells, [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) binding at all three centromeres was not significantly different from its binding in WT cells in either [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ or [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ cells ([Figure 4, G--I](#fig4){ref-type="fig"}). However, [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) binding was significantly higher in [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)*-m2* than in WT cells ([Figure 4, G--I](#fig4){ref-type="fig"}; *P* \< 0.01 at [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528) and [9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528), and *P* \< 0.05 at [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528)). Levels of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) binding in [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)*-m2* cells were similar to levels in [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)*-m2* cells. These data suggest that [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528), but not [Rrm3](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528), promotes removal of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) in late S phase. Because [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) binds centromeres after centromere replication ([@bib9]), [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) removal likely occurs after centromere replication (discussed in more detail below). Also, the increased abundance of cen-RNA in [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ cells did not affect [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) binding ([Figure 4, G--I](#fig4){ref-type="fig"}).

Mutations that increase cen-RNA are associated with increased loss of a CEN6 mini-chromosome {#s19}
--------------------------------------------------------------------------------------------

Our studies identified three conditions where cen-RNA levels were elevated: [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ, [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ, and [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)*-m2* [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)*Δ* cells ([Figure 1](#fig1){ref-type="fig"}, [Figure 3](#fig3){ref-type="fig"}, and [Figure 4](#fig4){ref-type="fig"}). Levels of cen-RNA were also higher in [*htz1*](https://identifiers.org/bioentitylink/SGD:S000005372?doi=10.1534/genetics.119.302528)Δ cells ([@bib28]). To assess if increased cen-RNA is associated with changes in chromosome stability, we determined the loss rate of a [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528) mini-chromosome at 30° in WT and mutant cells ([Figure 5A](#fig5){ref-type="fig"}).

![Stability of a [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528) plasmid and 2D gel analysis of replication of the chromosomal [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528) locus, in mutant and WT strains. Methods for determining [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528) plasmid loss rates and 2D gels are described in the *Materials and Methods*, and in [@bib9]. (A) CEN plasmid loss rate in WT and mutant strains growing at 30° in YPD. Loss rates for strains above the horizontal red line are from [@bib9]. The second column is the loss rate ± 1 SD for the indicated strain. Asterisks indicate significant differences: black asterisks are significant differences in loss rate of the indicated strain compared to loss rate in WT cells; red asterisks are significant differences between indicated strain and [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ cells; green asterisks are significant differences between indicated strain and [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ cells; blue asterisks are significant differences between indicated strain and [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells; and purple asterisks indicate significant differences between indicated strain and [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)Δ (or [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)*-m2*) [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ cells. (B) 2D gel electrophoresis and Southern blot hybridization of replication through the chromosomal [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528) locus in 30°-grown asynchronous WT and mutant cells growing in YPD. DNA was isolated, digested with *Mfe*I restriction enzyme, and analyzed by 2D gels and Southern blotting. (B) Schematic of the chromosomal *Mfe*I fragment that contains [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528) (open circle) relative to the replication origins (open boxes) on either side. The position of the radiolabeled probe used for Southern blot analysis is indicated. (C) Schematic of 2D gel signal of *Mfe*I-digested DNA using the probe indicated in (B). Arrows mark the pauses at [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528) along the arc of Y-shaped replication intermediates. The pause produced from replication forks originating from *ARS605* are indicated by the open arrow, whereas the pause arising from forks originating from *ARS606* are indicated by the solid arrow. 1N indicates nonreplicating linear *Mfe*I fragments. 2N indicates near-fully replicated *Mfe*I fragments. (D--K) Southern blots of 2D gels from cells of the following genotypes: (D) WT, (E) [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ, (F) [*tof1*](https://identifiers.org/bioentitylink/SGD:S000005217?doi=10.1534/genetics.119.302528)Δ, (G) [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ [*tof1*](https://identifiers.org/bioentitylink/SGD:S000005217?doi=10.1534/genetics.119.302528)Δ, (H) [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ, (I) [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ, (J) [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ, (K) [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ, and (L) [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ [*tof1*](https://identifiers.org/bioentitylink/SGD:S000005217?doi=10.1534/genetics.119.302528)Δ. The signal at the pause was quantified ([@bib50]) and normalized to the pause signal in WT cells to obtain the relative fold change. The average fold difference of mutant over WT from two or more independent biological replicates is shown in the upper right corner of each panel. 2D gel data for [*tof1*](https://identifiers.org/bioentitylink/SGD:S000005217?doi=10.1534/genetics.119.302528)Δ and [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ were published previously ([@bib9]). 2D, two-dimensional; WT, wild-type.](465f5){#fig5}

We reported recently that the loss rate of this [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528) mini-chromosome was 3.4× higher in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ (7.8% loss per cell division) and 3.0× higher in [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)Δ [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ (6.9%) compared to WT cells (2.3% loss rate) (*P* \< 0.01 for both strains) ([@bib9]). For convenience, these previously published values are shown in [Figure 5A](#fig5){ref-type="fig"}. Likewise, mini-chromosome loss was significantly higher in [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ (3.8%) and [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ [*rnh201*](https://identifiers.org/bioentitylink/SGD:S000005016?doi=10.1534/genetics.119.302528)Δ (4.6%) compared to WT cells (1.7× and 2× higher than WT; [Figure 5A](#fig5){ref-type="fig"}; the rate in [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ [*rnh201*](https://identifiers.org/bioentitylink/SGD:S000005016?doi=10.1534/genetics.119.302528)Δ was not significantly different from the rate in [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ cells; *P* \> 0.05).

We also determined the loss rates of the [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528) mini-chromosome in double and triple mutants. The loss rate in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ cells (9.0%) was significantly higher than in [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ cells (3.8%, *P* \< 0.0001) or [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells (7.8%, *P* \< 0.0001), indicating that [Rnh1](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528) and [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) affected mini-chromosome stability by different mechanisms, just as they affected cen-RNA levels by different mechanisms ([Figure 3, A--C](#fig3){ref-type="fig"}). Likewise, [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528) mini-chromosome loss was higher in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)Δ cells (16%) than in either [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ (7.8%) or [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)Δ [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ cells (6.9%) (*P* \< 0.001) ([Figure 5A](#fig5){ref-type="fig"}). [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528) mini-chromosome loss rates were similar in [*pif1*](https://www.yeastgenome.org/locus/S000004526)*-m2* [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ (6.9%) *vs.* [*pif1*](https://www.yeastgenome.org/locus/S000004526)*-m2* [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ (7.1%) (*P* \> 0.05) cells, but higher than in [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ (3.8%) cells (*P* \< 0.05). [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) and, especially, [Rrm3](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528) promote replication through centromeres ([@bib9]), which probably contributes to their role in centromere function. This interpretation is supported by the two times higher loss rate of the [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528) mini-chromosome in [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ cells ([Figure 5A](#fig5){ref-type="fig"}), which had WT levels of cen-RNA ([Figure 4, A--C](#fig4){ref-type="fig"}). A [CEN8](https://identifiers.org/bioentitylink/SGD:S000006469?doi=10.1534/genetics.119.302528) mini-chromosome is also lost at elevated rates in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ (around four times higher than WT), [*htz1*](https://identifiers.org/bioentitylink/SGD:S000005372?doi=10.1534/genetics.119.302528)Δ (∼2.8×), and [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ [*htz1*](https://identifiers.org/bioentitylink/SGD:S000005372?doi=10.1534/genetics.119.302528)Δ (13.5×) cells ([@bib28]).

Cbf1, but not RNA--DNA hybrids, slows fork progression during centromere replication {#s20}
------------------------------------------------------------------------------------

Replication forks pause as they move through centromeres, due at least in part to the Cbf3 protein complex that is centromere-associated during most of the cell cycle ([@bib15]). From analogy with Cbf3, [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) might also impede fork progression. In this model, fork progression through centromeres should be improved in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells owing to the removal of a protein impediment to fork progression. Another possibility is that [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) affects pausing by suppressing the production of cen-RNA. In this model, fork pausing should increase in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ compared to WT cells, as cen-RNA levels were high throughout the cell cycle in this strain ([Figure 1, B--D](#fig1){ref-type="fig"}). In other contexts, R-loops cause fork stalling. If yeast cen-RNA is in R-loops at the time of centromere replication, R-loops might impede fork progression at centromeres. This model predicts that stalling should be stronger in [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ compared to WT cells.

To test these possibilities, we used 2D gel electrophoresis to study replication through chromosomal [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528) in WT and mutant cells ([Figure 5, B--L](#fig5){ref-type="fig"}). The 2D gel analysis showed that pausing was reduced at [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528) in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells (∼0.4× WT; [Figure 5E](#fig5){ref-type="fig"}; the numbers in the upper right-hand corner of the 2D gel panels indicate the levels of pausing at the centromere relative to pausing in WT cells). These data suggest that the physical presence of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) is responsible for about one-half of the replication pausing at the chromosome VI centromere. This interpretation is supported by 2D gel analysis in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ [*tof1*](https://identifiers.org/bioentitylink/SGD:S000005217?doi=10.1534/genetics.119.302528)Δ cells ([Figure 5G](#fig5){ref-type="fig"}). [Tof1](https://identifiers.org/bioentitylink/SGD:S000005217?doi=10.1534/genetics.119.302528) stabilizes nonnucleosomal protein complexes, making them greater obstacles for fork progression ([@bib18]). As fork stalling at [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528) was almost undetectable in the double mutant ([Figure 5G](#fig5){ref-type="fig"}), the negative impact of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) on fork progression is due to its physical presence. An inference from these data is that [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) is centromere-associated at the time of centromere replication. This finding supports the conclusion that centromere transcription occurs after DNA replication, as inferred from the timing of its appearance ([Figure 1](#fig1){ref-type="fig"}) and the timing of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) removal ([Figure 2](#fig2){ref-type="fig"}). Additionally, fork pausing at [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528) was similar in [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ and WT cells (0.9× WT; [Figure 5H](#fig5){ref-type="fig"}), and in [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ and [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells (0.4× WT; [Figure 5I](#fig5){ref-type="fig"}). Thus, R-loops are not responsible for fork pausing at centromeres.

[Rrm3](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528) promotes fork progression past protein complexes at many sites, including centromeres. Thus, pausing at centromeres is around three times higher in its absence than in WT cells ([@bib20]; [@bib9]) (see also [Figure 5J](#fig5){ref-type="fig"}). About one-half of this pausing remained in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ cells (1.5× WT; [Figure 5K](#fig5){ref-type="fig"}). These data indicate that [Rrm3](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528) promotes replication past CEN-bound [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528), but [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) is not the only Rrm3-sensitive replication obstacle at centromeres. Pausing was reduced even more in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ [*tof1*](https://identifiers.org/bioentitylink/SGD:S000005217?doi=10.1534/genetics.119.302528)Δ cells (0.6× WT; [Figure 5L](#fig5){ref-type="fig"}). Together, the 2D gels show that proteins, not R-loops, cause pausing at centromeres. These data also establish that defects in fork progression do not explain increased mini-chromosome loss in either [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ or [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ cells (but they could in [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ cells) ([Figure 5A](#fig5){ref-type="fig"}).

Cbf1 is required for proper levels of Cse4 binding, especially in G1 and S phase {#s21}
--------------------------------------------------------------------------------

Although CENP-A interacts with cen-RNA in flies, mouse, humans, and corn ([@bib5]; [@bib48]), we did not detect cen-RNA association with immunoprecipitated epitope-tagged [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) in WT or [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells (A. Chan, data not shown). As an alternative approach to detect an impact of cen-RNAs on [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528), we asked if elevated levels of cen-RNA altered [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) centromere binding. We used ChIP to determine [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding to six different centromeres in WT and mutant cells, where cen-RNA was more abundant throughout the cell cycle ([*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ) or only in late S/G2 phase ([*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ and [*pif1*](https://www.yeastgenome.org/locus/S000004526)*-m2* [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ cells; [Figure 6](#fig6){ref-type="fig"}). The tested mutations increased cen-RNA levels to different extents: 5--12× ([*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ), ∼2× ([*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ), or ∼2--3× ([*pif1*](https://www.yeastgenome.org/locus/S000004526)*-m2* [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ) ([Figure 1](#fig1){ref-type="fig"}, [Figure 3](#fig3){ref-type="fig"}, and [Figure 4](#fig4){ref-type="fig"}). As a negative control, we examined [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding to the right telomere of chromosome VI ([Figure 6G](#fig6){ref-type="fig"}).

![Altered levels of cen-RNA correlate with changes in [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) centromere binding. Scatter plots of Cse4-Myc9 binding to centromeres in asynchronous WT and mutant cells growing in YPD at 30°, as determined by ChIP. (A) [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528), (B) [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528), (C) [CEN9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528), (D) [CEN11](https://identifiers.org/bioentitylink/SGD:S000006472?doi=10.1534/genetics.119.302528), (E) [CEN12](https://identifiers.org/bioentitylink/SGD:S000006473?doi=10.1534/genetics.119.302528), (F) [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528), and (G) VI-R telomere (control). Quantified as (\[ChIP/Input\] ~Target\ site~/\[ChIP/Input\] [*~ARO1~*](https://identifiers.org/bioentitylink/SGD:S000002534?doi=10.1534/genetics.119.302528)). Cross bars indicate means and SD. The paired two sample for means Student's *t*-test, with the hypothesized mean difference set at 0, was used to calculate significance. In all figures, \* *P* ≤ 0.05, \*\* *P* ≤ 0.01, \*\*\* *P* ≤ 0.001, and \*\*\*\* *P* ≤ 0.0001. Graphs show data points from several ChIP experiments consisting of three biological replicates per experiment. (H) Table showing centromeres and strains where there were significant changes in [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding compared to binding at the same CEN in WT cells. The third column shows fold change in [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding in the indicated mutants relative to WT. The scales for [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) and telomere VI-R are different from those of other panels in the figure. cen-RNA, centromeric RNA; ChIP, chromatin immunoprecipitation; NS, no significance; WT, wild-type.](465f6){#fig6}

Compared to WT, at five of the six centromeres, [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding was significantly higher in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells (1.8--2.7× higher; *P*-values 0.01--0.0001; [Figure 6, A--E](#fig6){ref-type="fig"}), while at [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528), [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding was significantly lower in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells (0.6× WT; [Figure 6F](#fig6){ref-type="fig"}; *P* = 0.001) (see [Figure 6H](#fig6){ref-type="fig"} for fold differences in binding and individual *P*-values.) However, the level of [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding to [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) in WT cells was ∼5--10× higher than at the other five centromeres. Therefore, even though [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding to [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) was lower in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ compared to WT cells, this level of binding was still higher than the increased [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding to the other five centromeres in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells. There were no significant effects of [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ, [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ, or [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)*-m2* ([Figure 6](#fig6){ref-type="fig"}) on [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding at any of the six centromeres (*P* \> 0.05). In [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)*-m2* [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ cells, [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding was significantly changed (*P* \< 0.05) only at [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528), where [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding was 0.4× lower than in WT cells ([Figure 6, F and H](#fig6){ref-type="fig"}).

There are at least two explanations for why [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding was perturbed in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ but not [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ or [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)*-m2* [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ cells. First, cen-RNA levels were higher in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells than in the other two mutant strains, and higher levels might be necessary to impact [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding. Second, in contrast to [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ and [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)*-m2* [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ cells where the increase in cen-RNA was limited to late S/G2 phase ([Figure 3](#fig3){ref-type="fig"} and [Figure 4, D--F](#fig4){ref-type="fig"}), cen-RNA was more abundant throughout the cell cycle in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells ([Figure 1, B--D](#fig1){ref-type="fig"}). Thus, a second hypothesis to explain the effects of [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ on [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding is that it is due to the unscheduled production of cen-RNA.

To distinguish between the two possibilities, we examined [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding in [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells, which had even higher cen-RNA levels than [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells ([Figure 3, A--C](#fig3){ref-type="fig"}). Thus, if more cen-RNA was the cause of altered [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding, [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding should be affected more in [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells than in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells. However, [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding was not significantly different (*P* \> 0.05) in [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ *vs.* [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells at any of the six centromeres. Together, these results suggest that it is not high cen-RNA levels *per se* that impact [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding, but rather its unscheduled production.

We also examined [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding to four centromeres in synchronous cultures of WT and [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells ([Figure 7](#fig7){ref-type="fig"}). At [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528), [6](https://www.yeastgenome.org/locus/S000001896), and [9](https://www.yeastgenome.org/locus/S000006470), [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding was constant throughout the cell cycle in WT cells ([Figure 7, A--C](#fig7){ref-type="fig"}; blue squares). Again, [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) was different from the other centromeres: (1) in WT cells, [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding in G1 phase was ∼3--9× higher than at the other centromeres, and (2) [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding increased as cells moved through S phase to the end of the cell cycle.

![The timing of [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding is altered in synchronized [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells. Myc9-tagged [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding to different centromeres was determined by ChIP in synchronized cells grown at 24° in YPD in WT and [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells. Data are presented as (\[ChIP/Input\]~Target\ site~/\[ChIP/Input\]*~ARO~*). The binding of [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528)-Myc9 in WT (blue squares) and [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ (red circles) cells at (A) [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528), (B) [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528), (C) [CEN9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528), and (D) [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528). Blue and red bars indicate approximate positions in the cell cycle as determined by FACS in, respectively, WT and [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells (see Figure S1A). For [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528) (A) and [CEN9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528) (C), binding was significantly higher in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells than in WT cells from 0 to 75 min (*P* \< 0.05). For [CEN6](https://identifiers.org/bioentitylink/SGD:S000001896?doi=10.1534/genetics.119.302528) (B), binding was significantly higher in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells than in WT cells from 0 to 30 or 45 min (*P* \< 0.05). At CEN 13 (D), [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding was significantly lower in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells than in WT cells only at 75 and 105 min (*P* \< 0.01). However, binding of [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) to [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) in WT cells was significantly higher than to any of the three other centromeres throughout the cell cycle (*P* \< 0.05). (E) Table showing time points for each centromere where [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding was significantly different from that in WT cells. For each time point, fold change is the difference at that time point in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells compared to WT. (F) Analysis of sequences for [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528) (chosen because it has a nonpalindromic CDEI site), [CEN9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528) (chosen because it has a palindromic CDEI site), [CEN8](https://identifiers.org/bioentitylink/SGD:S000006469?doi=10.1534/genetics.119.302528), and [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528). Blue letters indicate CDEI site. Red color indicates CDEII site. Green color indicates CDEIII site. Purple color indicates a second potential Cbf1-binding site. Other than [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528), none of the other 15 centromeres has an additional CDEI consensus site \< 1000 bp from the core centromere. CDE, conserved elements; ChIP, chromatin immunoprecipitation; WT, wild-type.](465f7){#fig7}

In the absence of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528), [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding was significantly higher in G1 and through much of S phase at [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528), [6](https://www.yeastgenome.org/locus/S000001896), and [9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528) (1.7--4.5× increase; [Figure 7, A--C](#fig7){ref-type="fig"}; red circles). However, this increase was most dramatic in G1/early S phase. Again, the pattern was different at [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528): [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding was similar to binding in WT cells except at two time points (75 and 105 min, *P* \< 0.01) when binding was significantly lower than in WT cells ([Figure 7D](#fig7){ref-type="fig"}). Thus, both the timing and amount of [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding are disturbed in the absence of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528).

In contrast to our results, a recent paper concluded that [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) chromatin binding is reduced in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells ([@bib28]). The authors used chromosome spreads to monitor [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding and found that ∼100% of WT cells had a single cluster of [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding, while only ∼85% did in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells. However, yeast centromeres are clustered in WT but to a lesser extent in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells (E. Yeh and K. Bloom, personal communication). The most likely explanation for the different results by the two groups is that [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding to centromeres is difficult to detect by chromosome spreads when centromeres are not clustered. Moreover, ChIP is a much more quantitative assay than chromosome spreads as it determines binding at individual centromeres rather than on a per-cell basis.

Atypical behavior of CEN13 can be explained by its having two Cbf1-binding sites {#s22}
--------------------------------------------------------------------------------

Despite the relative uniformity of the 16 yeast centromeres, [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) often had different properties than the other centromeres. Like [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528) and [9](https://www.yeastgenome.org/locus/S000006470), [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) RNA levels were RNaseH1-sensitive in mid--late S phase ([Figure 1, B--D](#fig1){ref-type="fig"}; blue squares and [Figure 3](#fig3){ref-type="fig"}). However, the amount of cen-RNA at [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) was much lower than at [CEN3](https://identifiers.org/bioentitylink/SGD:S000006465?doi=10.1534/genetics.119.302528) or [CEN9](https://identifiers.org/bioentitylink/SGD:S000006470?doi=10.1534/genetics.119.302528) ([Figure 1, E--G](#fig1){ref-type="fig"}). The cell cycle pattern of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) binding to [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) was the same as at other centromeres ([Figure 2, A--D](#fig2){ref-type="fig"}), but the level of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) binding to [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) was two-to-three times higher than at the other centromeres ([Figure 2, E--H](#fig2){ref-type="fig"}), and deletion of [CBF1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) had an almost two times greater effect on the level of [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) cen-RNA than on other cen-RNAs ([Figure 1, E--G](#fig1){ref-type="fig"}). Compared to five other centromeres, [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding was 5--10× higher at [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) in WT cells ([Figure 6, A--F](#fig6){ref-type="fig"}). Thus, at [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528), higher [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) binding was associated with lower cen-RNA and higher [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528).

An examination of the sequence of the 16 yeast centromeres suggests an explanation for the atypical behavior of [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) ([Figure 7F](#fig7){ref-type="fig"}). There are two [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) consensus binding sites near [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528), one at CDEI and another 97 bp upstream of CDEI ([Figure 7F](#fig7){ref-type="fig"}). We speculate that occupancy of this second site explains why there was less cen-RNA and more [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) at [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528). The only other centromere with a second nearby [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) consensus binding site is [CEN8](https://identifiers.org/bioentitylink/SGD:S000006469?doi=10.1534/genetics.119.302528), but this site is 1000 bp downstream of CDEI ([Figure 7F](#fig7){ref-type="fig"}). Because single CBF1-binding sites are only occupied near centromeres ([@bib6]; [@bib22]), the second [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) site at [CEN8](https://identifiers.org/bioentitylink/SGD:S000006469?doi=10.1534/genetics.119.302528) is probably not occupied. Perhaps, the doubling of Cbf1-binding sites at [CEN13](https://identifiers.org/bioentitylink/SGD:S000006474?doi=10.1534/genetics.119.302528) is a precursor of the centromeric heterochromatin seen at regional centromeres.

Discussion {#s23}
==========

In agreement with [@bib28]), we show that cen-RNA was present in very low amounts in WT yeast. Low abundance of cen-RNA is conserved, as in multicellular eukaryotes, it is estimated to be present in about a one-to-one ratio with the DNA from which it is transcribed ([@bib48]). In addition, yeast cen-RNA was detected during a narrow window of the cell cycle that corresponded to mid--late S phase, which reduced its level on a per-cell basis even more ([Figure 1, B--D](#fig1){ref-type="fig"}).

Levels of cen-RNA increased 5--12×, and cell cycle-limited expression of cen-RNA was lost in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells ([Figure 1, B--G](#fig1){ref-type="fig"}) ([@bib28]). Consistent with [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) being a negative regulator of cen-RNA, [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) binding to centromeres was low when cen-RNA levels were high ([Figure 2, A--D](#fig2){ref-type="fig"}). Thus, [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)-mediated repression of cen-RNA likely involves centromere binding. However, [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) is unlikely to bind to the cen-RNA promoters, as cen-RNAs are much larger (462--1754 nt) than the core centromere ([@bib28]). In WT cells, [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) binds to all centromeres ([@bib9]) at about the time that cen-RNA appeared ([Figure 1](#fig1){ref-type="fig"}). As [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) binding was higher in [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)*-m2* cells ([Figure 4, G--I](#fig4){ref-type="fig"}), [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) may use its protein eviction activity ([@bib23]) to displace [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) from centromeres.

Cen-RNA was also elevated in [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ ([Figure 3](#fig3){ref-type="fig"}) and [*pif1*](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)*-m2* [*rrm3*](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528)Δ cells ([Figure 4](#fig4){ref-type="fig"}). However, in contrast to the increased cen-RNA in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells, the extent of the increase in these strains was more modest (two-to-threefold) and was limited to mid--late S phase. As the only known activity of RNAseH1 is the removal and degradation of RNA in RNA--DNA hybrids, the cen-RNA increase in [*rnh1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528)Δ cells ([Figure 3](#fig3){ref-type="fig"}) suggests a model where some or all of the cen-RNA in WT cells in mid--late S phase is in R-loops. This conclusion is consistent with the [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)/[Rrm3](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528) sensitivity of cen-RNA ([Figure 4](#fig4){ref-type="fig"}), as [Pif1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528) family helicases are very efficient at releasing RNA from RNA--DNA hybrids ([@bib2]; [@bib55]; [@bib33]). An R-loop structure for cen-RNA, combined with its transient occurrence, can explain why cen-RNA is present in very low amounts, not only in *S. cerevisiae* but also in multicellular organisms. Thus, R-loops may be a conserved feature of cen-RNAs ([@bib21]).

However, other data argue against an R-loop model for *S. cerevisiae* cen-RNA. Specifically, several groups do not detect cen-RNA in WT cells by immunoprecipitation with the S9.6 antibody that detects R-loops ([@bib14]; [@bib46]; [@bib52]) (our unpublished results). At this point, it is not clear how to reconcile these conflicting data. One possibility is that difficulties detecting yeast cen-RNAs with the S9.6 antibody are due to their transient occurrence, as S9.6 detects centromeric R-loops at all *S. cerevisiae* centromeres in [*hpr1*](https://identifiers.org/bioentitylink/SGD:S000002545?doi=10.1534/genetics.119.302528)Δ cells, a strain where R-loops throughout the genome have longer half-lives ([@bib7]). Nonetheless, more data are needed to establish that *S. cerevisiae* cen-RNAs are in R-loops.

In addition to affecting cen-RNA, loss of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) also correlated with changes in the timing and levels of [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding ([Figure 6](#fig6){ref-type="fig"} and [Figure 7, A--D](#fig7){ref-type="fig"}). Both high levels of cen-RNA and its unscheduled appearance were needed to affect [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding. The budding yeast centromere is associated with a single [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) nucleosome ([@bib11]; [@bib24]), but there is some [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) in centromere-proximal regions that is not involved in kinetochore assembly ([@bib10]; [@bib26]; [@bib16]). One explanation for the increased centromere-associated [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells is that the pool of centromere-peripheral [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) is higher in this background. If so, based on a shear size of ∼300 bp and the primers used to amplify centromeric DNA ([Figure 1A](#fig1){ref-type="fig"}), the additional [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) must be bound within ∼300 bp from the core centromere. An increase in peripheral [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) binding might be facilitated by the absence of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) and perhaps lead to competition for kinetochore assembly between the two closely spaced [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) sites, thereby impairing segregation fidelity. Another possibility is that the composition of the single [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) nucleosome is changed in [*cbf1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528)Δ cells, as it is not clear if there are one or two [Cse4](https://identifiers.org/bioentitylink/SGD:S000001532?doi=10.1534/genetics.119.302528) molecules per centromeric nucleosome ([@bib1]).

In combination, the data in this paper suggest the following working model for centromere transcription. In this model, loss of [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) binding in mid--late S phase allows centromere transcription. As [Cbf1](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528) was centromere-associated at the time of centromere replication, centromere transcription must occur after centromere replication ([Figure 5G](#fig5){ref-type="fig"}). The low levels of cen-RNA shown here and in [@bib28] suggest that in WT cells, each centromere is transcribed no more than once (or a very few times) in a given cell cycle. If *S. cerevisiae* cen-RNAs remain base-paired to centromeric DNA, as they do in human cells ([@bib21]), it would explain why there are so few rounds of transcription. Our model also proposes that the absence of cbf1 allows the occurrence of multiple rounds of centromere transcription throughout a given cell cycle, and this free cen-RNA might interfere with kinetochore assembly.

Given the ubiquitous nature of cen-RNAs, it seems reasonable that they affect one or more aspects of centromere function rather than being low-level noise in the system. Consistent with this idea, in diverse organisms, positive and negative changes in cen-RNA abundance affect chromosome stability. However, establishing direct roles for cen-RNAs is challenging. Part of the difficulty is that many of the genes whose mutation affect cen-RNA have other functions. For example, while deletion of [*CBF1*](https://identifiers.org/bioentitylink/SGD:S000003821?doi=10.1534/genetics.119.302528), [PIF1](https://identifiers.org/bioentitylink/SGD:S000004526?doi=10.1534/genetics.119.302528)/[RRM3](https://identifiers.org/bioentitylink/SGD:S000001073?doi=10.1534/genetics.119.302528), [*RNH1*](https://identifiers.org/bioentitylink/SGD:S000004847?doi=10.1534/genetics.119.302528), and [*HTZ1*](https://identifiers.org/bioentitylink/SGD:S000005372?doi=10.1534/genetics.119.302528) increased both cen-RNA and centromere dysfunction ([Figure 5A](#fig5){ref-type="fig"}) ([@bib28]), each of these genes is pleiotropic, so the increased centromere instability associated with their loss may be linked to a phenotype other than increased cen-RNA. Nonetheless, it is striking that although each of the four mutations increase cen-RNA by different mechanisms, mini-chromosome loss was elevated in each strain.

Supplemental material available at Figshare: <https://doi.org/10.25386/genetics.8939873>.
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